YELLOW Sitting out on mixed signals.
Quality over quantity
Regime: YELLOW
The Picks
| Ticker | Scan Price | Gap % | RVOL | Catalyst | ML Hold Prob | ML Expected |
|---|---|---|---|---|---|---|
| KMX | $59.67 | 4.30 | 30.49 | Earnings: CarMax Q2 2027 earnings conference call transcript released, with next earnings scheduled for September 29, 2026. | — | — |
| BB | $8.83 | 7.55 | 22.16 | Contract: BlackBerry's QNX secured a major contract with a German automaker for HCT Luna solution with projected volumes of several million units within three years. | — | — |
| CCL | $24.50 | 10.11 | 17.34 | Earnings: Carnival beat Q3 earnings and sales estimates, though Q4 guidance disappointed versus expectations, partially offset by raised FY2026 EPS guidance. | — | — |
| ABCL | $14.19 | 11.73 | 22.04 | Analyst: JP Morgan initiates coverage on AbCellera Biologics with an Overweight rating and $17 price target. | — | — |
| PTCT | $66.02 | 5.35 | 17.95 | No catalyst identified | — | — |
The Results
| Ticker | Entry | Entry Time | Exit | Exit Time | Method | P/L | % | Catalyst |
|---|---|---|---|---|---|---|---|---|
| KMX | $59.67 | Earnings: CarMax Q2 2027 earnings conference call transcript released, with next earnings scheduled for September 29, 2026. | ||||||
| BB | $8.83 | Contract: BlackBerry's QNX secured a major contract with a German automaker for HCT Luna solution with projected volumes of several million units within three years. | ||||||
| CCL | $24.50 | Earnings: Carnival beat Q3 earnings and sales estimates, though Q4 guidance disappointed versus expectations, partially offset by raised FY2026 EPS guidance. | ||||||
| ABCL | $14.19 | Analyst: JP Morgan initiates coverage on AbCellera Biologics with an Overweight rating and $17 price target. | ||||||
| PTCT | $66.02 | No catalyst identified |
Shadow Results
| Ticker | Shadow Entry | Shadow Exit | Exit Time | Method | Shadow P/L | % | Result | Catalyst |
|---|---|---|---|---|---|---|---|---|
| KMX | $59.67 | Earnings: CarMax Q2 2027 earnings conference call transcript released, with next earnings scheduled for September 29, 2026. | ||||||
| BB | $8.83 | Contract: BlackBerry's QNX secured a major contract with a German automaker for HCT Luna solution with projected volumes of several million units within three years. | ||||||
| CCL | $24.50 | Earnings: Carnival beat Q3 earnings and sales estimates, though Q4 guidance disappointed versus expectations, partially offset by raised FY2026 EPS guidance. | ||||||
| ABCL | $14.19 | Analyst: JP Morgan initiates coverage on AbCellera Biologics with an Overweight rating and $17 price target. | ||||||
| PTCT | $66.02 | No catalyst identified |
Things to Explore
Interested in our research, validation methodology, and trading system?
Get in TouchWork With Diana
Need a context architect to scaffold your AI agents and facilitate structured learning?
Visit goddev.aiThis post is part of a series documenting MorningEdge's development in real time. The knowledge base contains 0 books, papers, and lab reports totaling 0+ searchable chunks. The trading system described is paper trading only — no real capital is at risk.